Caligor Coghlan Pharma Services
Caligor Coghlan Pharma Services, a prominent player in the pharmaceutical services industry, is headquartered in the United States. Founded in 1974, the company has established itself as a leader in providing comprehensive supply chain solutions, clinical trial support, and logistics services tailored for the life sciences sector. With operational regions spanning North America and Europe, Caligor Coghlan is well-positioned to meet the diverse needs of its global clientele. The company’s core offerings include temperature-controlled logistics, clinical trial supply management, and custom packaging solutions, all designed to ensure the integrity and compliance of pharmaceutical products. Notably, Caligor Coghlan has achieved significant milestones, including strategic partnerships that enhance its market position. With a commitment to quality and innovation, Caligor Coghlan Pharma Services continues to set industry standards, making it a trusted partner for pharmaceutical and biotech companies worldwide.
DitchCarbon Score
How does Caligor Coghlan Pharma Services's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Caligor Coghlan Pharma Services's score of 23 is lower than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Caligor Coghlan Pharma Services's reported carbon emissions
Caligor Coghlan Pharma Services, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined. Without concrete figures or initiatives, it is challenging to assess their carbon footprint or sustainability efforts. However, the pharmaceutical industry is increasingly focusing on reducing greenhouse gas emissions and enhancing sustainability practices. Companies in this sector are often encouraged to adopt science-based targets and engage in climate pledges to mitigate their environmental impact. As such, Caligor Coghlan Pharma Services may be expected to align with these industry trends in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Caligor Coghlan Pharma Services is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
